Cargando…
Clinical Biomarkers and Pathogenic-Related Cytokines in Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a common autoimmune disease with unknown etiology and pathogenesis. Although major therapeutic advances have been made in recent years, there is no cure for the disease. Current medications mainly reduce inflammation in order to relieve pain and slow joint damage, but ma...
Autores principales: | Niu, Xiaoyin, Chen, Guangjie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4158303/ https://www.ncbi.nlm.nih.gov/pubmed/25215307 http://dx.doi.org/10.1155/2014/698192 |
Ejemplares similares
-
Cytokines as Biomarkers in Rheumatoid Arthritis
por: Burska, Agata, et al.
Publicado: (2014) -
Regulatory Effect of Iguratimod on the Balance of Th Subsets and Inhibition of Inflammatory Cytokines in Patients with Rheumatoid Arthritis
por: Xu, Yunzhi, et al.
Publicado: (2015) -
Pathogenic Role of Immune Cells in Rheumatoid Arthritis: Implications in Clinical Treatment and Biomarker Development
por: Yap, Hooi-Yeen, et al.
Publicado: (2018) -
Cytokine Networks in the Pathogenesis of Rheumatoid Arthritis
por: Kondo, Naoki, et al.
Publicado: (2021) -
B Cells in Rheumatoid Arthritis: From Pathogenic Players to Disease Biomarkers
por: Bugatti, Serena, et al.
Publicado: (2014)